Please Note: This trial is no longer enrolling new participants
ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity
Protocol No. | CTO-IUSCCC-0913 | Scope | Local |
---|---|---|---|
Principal Investigator | Tyler Shugg | Treatment Type | Screening |
Age Group | Adult | Phase | NA |